Applied Genetic Technologies reported $25.81M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Alimera Sciences ALIM:US $ 17.01M 4.41M
Applied Genetic Technologies AGTC:US $ 25.81M 1.7M
Avrobio Inc AVRO:US $ 17.13M 2.26M
Biogen BIIB:US $ 3946.6M 351.6M
Bluebird Bio BLUE:US $ 142.89M 10.1M
Celldex Therapeutics CLDX:US $ 14.56M 1.97M
Cti Biopharma CTIC:US $ 98.93M 32.28M
Gilead Sciences GILD:US $ 8558M 3052M
Insmed INSM:US $ 125.25M 9.92M
Intercept Pharmaceuticals ICPT:US $ 151.04M 15.78M
Life Technologies LIFE:US $ 6.27M 0.26M
Ophthotech OPHT:US $ 19.17M 9.04M
Regeneron Pharmaceuticals REGN:US $ 3007.6M 924.9M
Rigel Pharmaceuticals RIGL:US $ 59.22M 4.33M
Ultragenyx Pharmaceutical RARE:US $ 167.23M 14.14M